Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Recombinant Erythropoetin and Adjuvant I.V. Iron Therapy of Anemic Patients With Lymphoproliferative Disorders

NCT00145652 is registered in ClinicalTrials.gov with Sundsvall Hospital as lead sponsor.

NCT NCT00145652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00145652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Recombinant Erythropoetin and Adjuvant I.V. Iron Therapy of Anemic Patients With Lymphoproliferative Disorders
Lead sponsor
Sundsvall Hospital
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2003
Completion date
December 31, 2005
Enrollment
66
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic lymphocytic leukemia, multiple myeloma, non hodgkin lymphoma